Skip to content

Stress Reduction Study for Partners of Early Stage Dementia

A Daily Self-Regulation Intervention for Persons With Early Stage Alzheimer's Disease and Related Dementias and Their Spouses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03691428
Enrollment
90
Registered
2018-10-01
Start date
2019-01-30
Completion date
2021-06-30
Last updated
2024-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Caregiving

Brief summary

This is a study designed to pilot a WOOP (Wish Outcome Obstacle Plan) intervention for spouses of persons with early stage dementia for the purposes of future research. The investigators will be using two cohorts. One who will get the intervention and the other who will be wait listed and receive the intervention at a later date. Spouses of persons with dementia will use WOOP, a brief goal attainment sequence, every day for 16 days. Participants will complete surveys before the intervention, at Day 16, and at a 3-month follow-up. The outcome measures are goal attainment, emotion regulation skills, psychological health, and support quality. As of 9/2020 this entire study is being conducted remotely.

Interventions

BEHAVIORALWish Outcome Obstacle Plan

1\. Wish or goal: A wish (e.g. responding calmly when the partner asks a question repeatedly). 2. Outcome: The most positive outcome of realizing the wish or goal (e.g. both partners feel respected and happy). Then the participant vividly imagines the outcome. 3. Obstacle: The most critical internal, controllable, obstacle (e.g., feeling impatient). Then the participant vividly imagines the internal obstacle occurring. 4. Plan: The participant answers the following question: What action can I take or what thought can I think to overcome the obstacle (e.g., take a deep breath, take my partner's perspective, and answer the question calmly); then he or she forms an if \[specified obstacle - when I feel impatient\], then I will \[specified action or thought to overcome obstacle - take a deep breath, take my partner's perspective, and answer the question calmly\] plan.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Inclusion/

Exclusion criteria

* The couple is married or in a cohabiting, committed relationship. * One partner has early Adult Dementia (AD) or a related dementia using criteria: symptoms consistent with early-stage dementia or memory impairment (e.g., AD, vascular dementia) and scores on the Neuropsychiatric Inventory (NPI) ≥3; Mini-Mental State Examination (MMSE) ≥18 and ≤27; and Barthel Index (BI) ≥5 and ≤1923. Or\>20 on Telephone Interview for Cognitive Status. (TICS) * The spouse will have to score 27 or higher on the MMSE. Or\>25 on TICS. * Both participants must agree to participate and complete baseline interviews. * Both partners are at least 60 years old.

Design outcomes

Primary

MeasureTime frameDescription
Change in Perceived Stressbaseline, 3 monthsThe Perceived Stress Scale (PSS-10) will be used to examine participants' stress over the past week. There are 10 items rated on a scale from 0 to 4. Greater scores indicate greater stress. Sum scores can range from 0 to 40 with 40 being the highest stress and 0 being the lowest.
Change in Positive Affectbaseline, 3 monthsNine self-reported positive emotions (e.g., amusement, gratitude, hope) on a 1-5 scale over the past week using the Positive and Negative Affect Schedule (25 items). Higher scores indicate more positive emotions. Mean scores can range from 1 to 5 with 5 being the highest experience of positive emotions.
Change in Depressive Symptomsbaseline, 3 months10-item Center for Epidemiologic Studies of Depression Scale (CESD). Participants rate on a scale from 0 to 3. Higher numbers indicate more depressive symptoms. Sum scores can range from 0 to 30 with higher sums cores meaning more depressive symptoms.
Change in Quality of Lifebaseline, 3 monthsQuality of life was measured with the Quality of Life in Alzheimer's Disease (QOL-AD). The QOL-AD consists of 13 items that capture multiple aspects of a person's quality of life in the context of dementia. It can also be used to examine the quality of life of family members of persons with dementia. Participants rate on a 5-point scale from poor to excellent the degree to which they feel about different aspects of their life (e.g. physical health, energy, mood, memory, family). Sum scores can range from 13 to 65 with higher scores meaning higher quality of life.
Change in Negative Emotionsbaseline, 3 monthsTen negative (e.g., irritable, distressed) adjectives were measured with the Positive and Negative Affect Scale. Each item has a score of 1 (not at all) to 5 (extremely). The mean of the 10 items will be measured. Mean scores can range from 1 to 5 with 5 meaning the highest experience of negative emotions.

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention
Wish Outcome Obstacle Plan: 1. Wish or goal: A wish (e.g. responding calmly when the partner asks a question repeatedly). 2. Outcome: The most positive outcome of realizing the wish or goal (e.g. both partners feel respected and happy). Then the participant vividly imagines the outcome. 3. Obstacle: The most critical internal, controllable, obstacle (e.g., feeling impatient). Then the participant vividly imagines the internal obstacle occurring. 4. Plan: The participant answers the following question: What action can I take or what thought can I think to overcome the obstacle (e.g., take a deep breath, take my partner's perspective, and answer the question calmly); then he or she forms an if \[specified obstacle - when I feel impatient\], then I will \[specified action or thought to overcome obstacle - take a deep breath, take my partner's perspective, and answer the question calmly\] plan.
48
Wait-list
Participants will get the WOOP training after the last outcome assessment. Wish Outcome Obstacle Plan: 1. Wish or goal: A wish (e.g. responding calmly when the partner asks a question repeatedly). 2. Outcome: The most positive outcome of realizing the wish or goal (e.g. both partners feel respected and happy). Then the participant vividly imagines the outcome. 3. Obstacle: The most critical internal, controllable, obstacle (e.g., feeling impatient). Then the participant vividly imagines the internal obstacle occurring. 4. Plan: The participant answers the following question: What action can I take or what thought can I think to overcome the obstacle (e.g., take a deep breath, take my partner's perspective, and answer the question calmly); then he or she forms an if \[specified obstacle - when I feel impatient\], then I will \[specified action or thought to overcome obstacle - take a deep breath, take my partner's perspective, and answer the question calmly\] plan.
42
Total90

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject68

Baseline characteristics

CharacteristicTotalInterventionWait-list
Age, Continuous
care partners
74.0 years72.3 years76 years
Age, Continuous
persons with dementia
76.4 years75.8 years77.2 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
6 Participants3 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants2 Participants0 Participants
Race (NIH/OMB)
White
82 Participants43 Participants39 Participants
Region of Enrollment
United States
90 participants48 participants42 participants
Sex: Female, Male
Female
47 Participants25 Participants22 Participants
Sex: Female, Male
Male
43 Participants23 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 480 / 42
other
Total, other adverse events
0 / 480 / 42
serious
Total, serious adverse events
0 / 480 / 42

Outcome results

Primary

Change in Depressive Symptoms

10-item Center for Epidemiologic Studies of Depression Scale (CESD). Participants rate on a scale from 0 to 3. Higher numbers indicate more depressive symptoms. Sum scores can range from 0 to 30 with higher sums cores meaning more depressive symptoms.

Time frame: baseline, 3 months

Population: 20 caregivers in the intervention and 16 in the waitlist provided depression data at 3 months.

ArmMeasureValue (MEAN)Dispersion
InterventionChange in Depressive Symptoms5.4 units on a scaleStandard Deviation 5.07
Wait-listChange in Depressive Symptoms9.75 units on a scaleStandard Deviation 6.45
p-value: <0.05Mixed Models Analysis
Primary

Change in Negative Emotions

Ten negative (e.g., irritable, distressed) adjectives were measured with the Positive and Negative Affect Scale. Each item has a score of 1 (not at all) to 5 (extremely). The mean of the 10 items will be measured. Mean scores can range from 1 to 5 with 5 meaning the highest experience of negative emotions.

Time frame: baseline, 3 months

Population: 21 care partners in the intervention and 17 in the waitlist reported negative emotions at 3 months.

ArmMeasureValue (MEAN)Dispersion
InterventionChange in Negative Emotions1.8 score on a scaleStandard Deviation 0.54
Wait-listChange in Negative Emotions2.0 score on a scaleStandard Deviation 0.5
p-value: <0.05Mixed Models Analysis
Primary

Change in Perceived Stress

The Perceived Stress Scale (PSS-10) will be used to examine participants' stress over the past week. There are 10 items rated on a scale from 0 to 4. Greater scores indicate greater stress. Sum scores can range from 0 to 40 with 40 being the highest stress and 0 being the lowest.

Time frame: baseline, 3 months

Population: 3 month follow-up data for perceived stress was only provided by 21 care partners in the intervention condition and 17 in the wait-list condition.

ArmMeasureValue (MEAN)Dispersion
InterventionChange in Perceived Stress13.6 score on a scaleStandard Deviation 6.3
Wait-listChange in Perceived Stress17.8 score on a scaleStandard Deviation 13.6
p-value: <0.05Mixed Models Analysis
Primary

Change in Positive Affect

Nine self-reported positive emotions (e.g., amusement, gratitude, hope) on a 1-5 scale over the past week using the Positive and Negative Affect Schedule (25 items). Higher scores indicate more positive emotions. Mean scores can range from 1 to 5 with 5 being the highest experience of positive emotions.

Time frame: baseline, 3 months

Population: 21 care partners in the intervention and 17 in the wait-list had positive emotion data at 3 months.

ArmMeasureValue (MEAN)Dispersion
InterventionChange in Positive Affect3.60 score on a scaleStandard Deviation 0.61
Wait-listChange in Positive Affect3.20 score on a scaleStandard Deviation 0.87
p-value: <0.05Mixed Models Analysis
Primary

Change in Quality of Life

Quality of life was measured with the Quality of Life in Alzheimer's Disease (QOL-AD). The QOL-AD consists of 13 items that capture multiple aspects of a person's quality of life in the context of dementia. It can also be used to examine the quality of life of family members of persons with dementia. Participants rate on a 5-point scale from poor to excellent the degree to which they feel about different aspects of their life (e.g. physical health, energy, mood, memory, family). Sum scores can range from 13 to 65 with higher scores meaning higher quality of life.

Time frame: baseline, 3 months

Population: 21 care partners in the intervention and 17 in the waitlist group reported quality of life at 3 months.

ArmMeasureValue (MEAN)Dispersion
InterventionChange in Quality of Life41.5 score on a scaleStandard Deviation 6.9
Wait-listChange in Quality of Life35.5 score on a scaleStandard Deviation 7
p-value: <0.05Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026